Table 1 Patient and tumor characteristics (n = 44)
Mean age (range) | 56 | (24–78) y |
Gender | ||
Female | 10 | (23%) |
Male | 34 | (77%) |
Mean follow-up time (range) | 56 | (44–72) months |
since end of radiotherapy | ||
Tumor site | ||
Larynx | 19 | (43%) |
Floor of mouth/oral cavity | 7 | (16%) |
Oropharynx | 4 | (9%) |
Nose (nasal cavity) | 4 | (9%) |
Hypopharynx | 1 | (2%) |
Nasopharynx | 1 | (2%) |
Other | 8 | (18%) |
Surgery preradiotherapy | ||
Local | 6 | (14%) |
Local + regional | 11 | (25%) |
No | 27 | (61%) |
Stage (TNM staging system 1997) | ||
T1 | 7 | (22%) |
T2 | 16 | (50%) |
T3 | 5 | (16%) |
T4 | 4 | (12%) |
Not applicable/recurrent | 12 | |
N0 | 27 | (84%) |
N1 | 4 | (13%) |
N2b | 1 | (3%) |
Not applicable/recurrent | 12 |